Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy Adults

NCT00712803 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

NIH

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: rDEN3-3'D4delta30
BIOLOGICAL: rDEN3-3'D4delta30
BIOLOGICAL: rDEN3-3'D4delta30

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)